Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 12:48 PM

Ensysce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.21M 2.23M 2.52M 3.53M
Cost of Revenue
7.22M 7.59M 19.84M 151.00
Gross Profit
-2.01M -5.36M -17.31M 3.53M
Operating Income
-6.73M -10.72M -24.22M -19.87M
Interest Income
n/a n/a 1.25M 3.21M
Pretax Income
-7.99M -10.63M -24.21M -29.15M
Net Income
-7.99M -10.61M -24.17M -29.08M
Selling & General & Admin
4.72M 5.36M 6.91M 18.71M
Research & Development
7.22M 7.59M 19.84M 4.69M
Other Expenses
-7.22M -7.59M -19.84M -4.69M
Operating Expenses
4.72M 5.36M 6.91M 18.71M
Interest Expense
1.29M 353.94K 109.53K 1.29M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.94M 12.95M 26.75M 23.4M
Income Tax Expense
n/a n/a n/a -151
Shares Outstanding (Basic)
1.75M 2.26M 179.93K 84.02K
Shares Outstanding (Diluted)
1.75M 2.26M 179.93K 84.02K
EPS (Basic)
-4.57 -4.69 -139.44 -355.68
EPS (Diluted)
-4.57 -4.69 -139.44 -355.68
EBITDA
-6.73M -10.72M -24.22M -19.87M
EBIT
-6.73M -10.72M -24.22M -19.87M
Depreciation & Amortization
4.00 -3 151.00 151.00